drugset / Trial / NCT00603746

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.

NCT00603746

Phase 2 Completed 627 enrolled GlaxoSmithKline
RandomizedParallel-groupTreatment

Summary

This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.

Timeline

Start
2007-12-01
Primary completion
2008-09-01
Completion
2008-09-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Furoate Other / unclassified Inhaled

Indications